Article
Next-generation sequencing in breast cancer: current clinical applications and future directions
6 Oct 2025
Abstract excerpt
INTRODUCTION: Breast cancer is a heterogeneous disease that claims 670,000 lives by 2022. Omic technologies, particularly next generation sequencing (NGS) offers promising avenues for precision medicine. American Society of Clinical Oncology (ASCO) outlines genomic testing's utility, emphasizing prognostic and diagnostic potential. OBJECTIVES: This review succinctly explores NGS's evolution and clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
